Sleep and daytime sleepiness in methylphenidate medicated and un-medicated children with
K Cockcroft1, J Ashwal, A Bentley
1Department of Psychology, School of Human and Community Development (Psychology), University of the Witwatersrand, Johannesburg, South Africa. kate.cockcroft@wits.ac.za
Insights
Children with ADHD taking methylphenidate experienced increased sleepiness post-medication. This suggests methylphenidate may reduce daytime sleepiness, impacting learning in children with ADHD.
Area of Science:
- Pediatric Neurology
- Sleep Medicine
- Pharmacology
Background:
- Excessive daytime sleepiness can mimic Attention Deficit/Hyperactivity Disorder (ADHD) symptoms.
- Methylphenidate is a common ADHD treatment also used for excessive daytime sleepiness.
Purpose of the Study:
- To compare daytime sleepiness in medicated and un-medicated children with ADHD.
- To investigate the prevalence of sleep disorders in these groups.
Main Methods:
- Two matched groups of children diagnosed with ADHD were studied (n=12 medicated, n=11 un-medicated).
- Participants and parents rated daytime sleepiness levels throughout the day.
- Sleep disorders were assessed via parental reports.
Main Results:
- Parents reported significantly higher daytime sleepiness in un-medicated children (13:00-15:00).
- Medicated children showed increasing sleepiness after initial doses.
- No significant difference in sleep disorder prevalence between groups.
Conclusions:
- Methylphenidate may reduce daytime sleepiness in children with ADHD.
- Increased sleepiness post-medication could impact learning.
- Further research into methylphenidate's mechanism is warranted.
Objective:
Excessive daytime sleepiness due to any cause can result in various symptoms similar to those used for the diagnosis of attention deficit/hyperactivity disorder (ADHD). A common treatment for children diagnosed with ADHD is methylphenidate which is also used to treat excessive daytime sleepiness. This paper reports on a study which compared the perceived levels of daytime sleepiness and prevalence of sleep disorders in medicated and un-medicated children with ADHD.
Method:
The sample consisted of two matched groups of children who had been formally diagnosed with ADHD. One group (n=12) was taking immediate release methylphenidate twice daily, while the other group (n=11) had never, and were not currently, taking any medication. The two groups, as well as their parents, rated their levels of daytime sleepiness at three points in a single day.
Results:
Significantly higher levels of daytime sleepiness were reported by the parents of the un-medicated children between the hours of 13:00 and 15:00, compared to the medicated children. The medicated children became increasingly sleepier from the first to the second measurement in both the morning and afternoon. There was no significant difference in the number of sleep disorders/disruptions reported by the parents of either group.
Conclusion:
In a group of children with ADHD taking methylphenidate, there was a significant increase in sleepiness a few hours after taking the medication, which may then have a significant impact on their learning. The data also imply that part of the mechanism of action of methylphenidate effects in these children may be by reduction of daytime sleepiness.
More Related Videos
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Management of Insomnia
Narcolepsy
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids


